Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) ...

Fintel reports that on March 14, 2025, Goldman Sachs initiated coverage of 89bio (NasdaqGM:ETNB) with a Neutral ...

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmac ...

Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH) is a disease that occurs when ...

When mothers eat a diet high in fat and sugars, their unborn babies can develop liver stress that continues into early life.